Clinical Trials Browser

Phase 2 × OTHER × Risk Reduction Behavior × Clear all

NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Phase 2 Active not recruiting

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

NCT03346200 2025-03-07

KARISMA2

Phase 2 Completed

1,440 enrolled 14 charts

Breast Neoplasms, Risk Reduction Behavior